Company profile
Catalyst Pharmaceuticals, Inc.
small molecule specialty pharmaceuticals (rare/orphan neuromuscular and CNS disease)
Privately held: no public share price · Coral Gables, Florida, USA
Assets
(1 total)
1Total Assets
1Approved
0Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
Perampanel(Fycompa) | Approved | AMPA receptor (antagonist) · AMPA receptor (positive allosteric modulator)Small molecule | Epilepsy |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.